Synyoung Biomedics

Synyoung Biomedics is a South Korea-based for-profit medical diagnostic equipment supplier that has established itself as a critical vendor to the U.S. federal government, specifically serving the Defense Health Agency and military medical facilities overseas. The company is registered in SAM.gov with a UEI of M1VDMLLDVQN7 and maintains an active registration through July 30, 2026. Synyoung Biomedics specializes in providing radiometer blood gas analyzers and associated reagents that support medical diagnostic capabilities for U.S. military personnel and facilities stationed in South Korea.

Since October 2021, Synyoung Biomedics has received five delivery order awards totaling approximately $336,179 in contract value, all issued under firm fixed-price terms without set-aside designations through full and open competition. The company's federal contract work has been exclusively funded by the Defense Health Agency and the U.S. Army Medical Command, with all delivery orders supporting medical diagnostic operations at military facilities in South Korea, particularly the Brian D. Allgood Army Community Hospital. The specific goods provided across these delivery orders include radiometer arterial blood gas analyzer reagents, blood gas analyzers, and related diagnostic equipment. The delivery orders awarded include a $66,800 contract completed September 30, 2022; a $71,238 contract completed September 30, 2023; a $65,507 contract completed September 30, 2024; a $66,316 contract completed September 30, 2025; and a $66,316 contract with an ultimate completion date of September 30, 2026. All contracts have been issued as delivery orders rather than prime contracts, indicating Synyoung Biomedics operates as a vendor under larger federal contract vehicles.

Synyoung Biomedics holds a single-award Indefinite Delivery Contract (IDC) with the Defense Health Agency valued at $421,130, which was awarded on October 1, 2022, and extends through September 30, 2027. This IDC serves as an umbrella contract authorizing the Defense Health Agency to issue delivery orders for radiometer blood gas analyzers and associated reagents to support military medical facilities in South Korea. The IDC has generated substantial task order activity, with delivery orders totaling at least $336,179 already issued against the contract ceiling of $421,130. The contract operates on a firm fixed-price basis with no set-aside designations, and all procurement activity under this IDV has been conducted through full and open competition. The single-award nature of this IDC demonstrates that the Defense Health Agency has determined Synyoung Biomedics as the sole qualified source for this specialized medical diagnostic equipment and reagent supply requirement at military installations in South Korea.